treatment real encouraging said dr. annick desjardins director clinical research duke brain tumor center investigator poliovirus therapy study dr. andrew lassman chief neuro oncology newyork presbyterian columbia university medical center skeptical reviewing results stat request lassman not involved study encourage research area yield better outcomes particularly existing treatments glioblastoma ineffective patients said poliovirus therapy turn great data not conclude best approach phase 1 data presented 22nd international conference brain tumor research therapy norway simultaneously published study 61 patients recurrent glioblastoma treated poliovirus vaccine modified preferentially target protein found brain tumor cells set immune response surgeons implant catheter skull patients modified